The new value of Nigeria's GDP adds previously uncounted industries like telecommunications, information technology, music, airlines, burgeoning online retail outlets and Nollywood film production that didn't exist when the last GDP count was made in 1990. Then, there were 300,000 landlines. Today, Nigeria has 100 million cell phone users.
The new figures also will take account of growth in agriculture and tourism that have flourished since democracy was restored in 1999, ending decades of military dictatorship.
Best Performing Companies To Own In Right Now: Rigel Pharmaceuticals Inc.(RIGL)
Rigel Pharmaceuticals, Inc., a clinical-stage drug development company, engages in the discovery and development of small-molecule drugs for the treatment of inflammatory/autoimmune diseases, as well as for certain cancers and metabolic diseases. Its product development programs include R788, which completed a phase 2 clinical trial for the treatment of rheumatoid arthritis; and is in phase 2 clinical trials for B-cell lymphoma, T-cell lymphoma, immune thrombocytopenia purpura, and certain solid tumors. The company?s product development programs also comprise R343, which is in phase 1b clinical trial for the treatment of asthma. In addition, its preclinical programs include oral JAK3 inhibitor program for research in the area of immunology/inflammation; adiponectin mimetics for the treatment of type 2 diabetes mellitus and other potential indications; and muscle atrophy program for muscle homeostasis. Further, the company is evaluating R763/AS703569 compound in its aurora kinase inhibition program targeting cancer cell proliferation. Rigel Pharmaceuticals, Inc. has collaboration agreements with AstraZeneca AB; Pfizer, Inc.; and Daiichi Pharmaceuticals Co., Ltd. The company was founded in 1996 and is based in South San Francisco, California.
Advisors' Opinion:- [By Sean Williams]
What: Shares of Rigel Pharmaceuticals (NASDAQ: RIGL ) , a clinical-stage small molecule drug company focused on inflammatory and autoimmune disorders, dropped as much as 21% after the company resumed full responsibility for its rheumatoid arthritis pill, Fostamatinib, and reported topline data from two late-stage studies involving the drug.
- [By Max Macaluso, Ph.D.]
Early Tuesday morning, Rigel Pharmaceuticals� (NASDAQ: RIGL ) and its now-ex-partner, AstraZeneca (NYSE: AZN ) , reported late-stage clinical trial results for the experimental rheumatoid arthritis drug Fostamatinib. In the following video, health-care analyst Max Macaluso discusses why Rigel dropped 18% after the news was released and the risks that lie ahead for Rigel Pharmaceuticals.
- [By Maxx Chatsko]
Rigel Pharmaceuticals (NASDAQ: RIGL ) was kicked in the stomach earlier this month, when AstraZeneca (NYSE: AZN ) returned full rights for fostamatinib. The Big Pharma member decided to write off $140 million of assets attributed to the partnership rather than take the next steps in commercializing the drug for rheumatoid arthritis. Ouch. While it's a smart idea for AstraZeneca to walk away now, Rigel is in a tough spot with its top drug candidate receiving a vote of no confidence. There is a handful of companies that stand to benefit from fostamatinib's failure. In the following video, Fool contributor Maxx Chatsko explains what it means for investors and what the future could hold for the development-stage company. �
Top 10 Information Technology Stocks To Buy Right Now: NeurogesX Inc.(NGSX)
NeurogesX, Inc., a biopharmaceutical company, engages in developing and commercializing pain management therapies. The company offers Qutenza for the management of neuropathic pain associated with postherpetic neuralgia, and for the treatment of peripheral neuropathic pain in non-diabetic adults. It also develops NGX-1998, which has completed Phase 2 clinical study, is a topical liquid formulation of high concentration capsaicin to treat neuropathic pain conditions; and acetaminophen prodrugs that is in preclinical stage for use in acute pain, including traumatic pain, post-surgical pain, and fever. The company was formerly known as Advanced Analgesics, Inc. and changed its name to NeurogesX, Inc. in September 2000. NeurogesX, Inc. was founded in 1998 and is headquartered in San Mateo, California.
Advisors' Opinion:- [By CRWE]
Today, NGSX has shed (-6.67%) down -0.0005 at $.0070 with 29,206 shares in play thus far (ref. google finance Delayed: 10:44AM EDT July 17, 2013), but don�� let this get you down.
Acorda Therapeutics, Inc. previously reported it has acquired two neuropathic pain management assets from NeurogesX, Inc. (OTCBB: NGSX). Qutenza庐 is approved by the U.S. Food and Drug Administration (FDA) for the management of neuropathic pain associated with postherpetic neuralgia. The Company also acquired NP-1998, a Phase 3 ready, prescription strength capsaicin topical solution, being assessed for the treatment of neuropathic pain. NP-1998 was previously referred to as NGX-1998.
- [By CRWE]
Today, NGSX remains (0.00%) +0.000 at $.0054 thus far (ref. google finance Delayed: 11:59AM EDT July 18, 2013).
Acorda Therapeutics, Inc. previously reported it has acquired two neuropathic pain management assets from NeurogesX, Inc. (OTCBB: NGSX). Qutenza庐 is approved by the U.S. Food and Drug Administration (FDA) for the management of neuropathic pain associated with postherpetic neuralgia. The Company also acquired NP-1998, a Phase 3 ready, prescription strength capsaicin topical solution, being assessed for the treatment of neuropathic pain. NP-1998 was previously referred to as NGX-1998.
Top 10 Information Technology Stocks To Buy Right Now: Southern Cross Exploration NL (SXX)
Southern Cross Exploration NL is an Australia-based company engaged in the investment in the Bigrlyi Uranium Joint Venture, on which pre-development investigations and further drilling were carried out; exploration for gold and minerals, reviews of opportunities for participation in and/or acquisition of mineral exploration and mining ventures, and examination of projects in respect of different commodities, share investments, loans and other securities. The Bigrlyi project is located in the Ngalia Basin, northwest of Alice Springs, in the Northern Territory. The Company's interest in the Bigrlyi Uranium Joint Venture is one of its assets, in joint venture with two multi-billion dollar companies, CGNPC - via the Operator, Energy Metals Ltd (EME) - and Paladin Energy Ltd (PDN). Advisors' Opinion:- [By idahansen]
Due to the impact of The Great Recession, stocks in the agricultural sector such as Caterpillar (NYSE: CAT), The Mosiac Company (NYSE: MOS), and Potash of Saskatchewan (NYSE: POT) are trading well below highs. The exchange traded fund for the industry, DBA Power Shares, (NYSE: DBA), is down more than 17% for the last year. Despite this bearish trend, legendary investors such as Warren Buffett, George Soros, and Jim Rogers are very positive for the agriculture group. With the long term bullish outlook for the sector from the greatest investors in history, small cap stocks active in the fertilizer sector such as Sirius Minerals (LSE: SXX) and Americas Petrogas (TSX: BOE) are especially attractive.
Top 10 Information Technology Stocks To Buy Right Now: Compass Diversified Holdings (CODI)
Compass Diversified Holdings is a public investment firm specializing in acquiring controlling stakes in small to middle market companies. The firm seeks to make middle market and buyout investments. It seeks to invest in industries such as manufacturing, distribution, consumer products, and business services. The firm prefers to invest in companies based in North America with a preferred transaction size between $60 million and $300 million in value, cash flows between $5 million and $40 million, with enterprise values between $50 million and $250 million, and a minimum EBITDA of $10 million. It seeks to acquire controlling ownership interests in its portfolio companies and can also make additional platform acquisitions. The firm makes investments through balance sheet. Compass Diversified Holdings was founded in 2005 and is based in Westport, Connecticut. Compass Diversified Holdings operates as a subsidiary of The Compass Group LLC.
Advisors' Opinion:- [By Rick Munarriz]
I went out on a limb last week, and now it's time to see how that decision played out.
I predicted that Clean Energy Fuels (NASDAQ: CLNE ) would close higher on the week. The provider of natural gas fueling solutions for transportation has been posting narrowing losses, and Wall Street was eyeing a 35% surge in revenue. The company was a solid report. Revenue came in a little light, but bottom-line results improved nicely. Shares of Clean Energy Fuels moved slightly higher on the week. I was right. I predicted that the tech-heavy Nasdaq would outperform the Dow Jones Industrial Average. (DJINDICES: ^DJI ) . This has been a tricky call lately, so how did it play out this time? Well, the market had a strong run this week, fueled be encouraging economic news. Secondary stocks led the way, with the Nasdaq soaring 1.7% on the week. The Dow managed to close just 1% higher. I was right. My final call was for Compass Diversified Holdings (NYSE: CODI ) to beat Wall Street's quarterly profit target. The investor in several middle-market companies has been posting blowout quarterly results over the past year, and I was banking on seeing the trend continue. Analysts were looking for a profit of $0.36 a share during the quarter, but Compass Diversified failed to beat the prognosticators. I was wrong.Two out of three? I'll take it. That makes me eight of nine over the past three weeks.
- [By Eric Volkman]
Compass Diversified Holdings (NYSE: CODI ) is holding its dividend steady for its Q2. For the tenth quarter in a row, the company will pay a distribution of $0.36 per share, the company announced this week.
- [By Rich Smith]
Westport, Conn.-based Compass Diversified Holdings (NYSE: CODI ) will soon have a new CFO.
On Thursday, the diversified holding company of manufacturing, distribution, consumer products, and services businesses announced that current Chief Financial Officer James J. Bottiglieri intends to retire from the company on November 30, 2013. At that time, he will be replaced by newly promoted CFO Ryan J. Faulkingham (although Bottiglieri will remain on the Board of Directors).
Top 10 Information Technology Stocks To Buy Right Now: Textron Inc.(TXT)
Textron Inc. operates in the aircraft, defense, automobile, industrial, and finance businesses worldwide. It operates in five segments: Cessna, Bell, Textron Systems, Industrial, and Finance. The Cessna segment manufactures business jets, single engine turboprops, and single engine piston aircraft, as well as provides aftermarket services. The Bell segment manufactures and supplies military and commercial helicopters, tiltrotor aircraft, and related spare parts and services. The Textron Systems segment produces armored security vehicles, marine craft, precision weapons, airborne and ground-based surveillance systems and services, the unmanned aircraft system, training and simulation systems and countersniper devices, and intelligence and situational awareness software. The Industrial segment offers blow-molded plastic fuel systems, windshield and headlamp washer systems, engine camshafts, plastic bottles, and containers; powered equipment, electrical test and measurement i nstruments, hand and hydraulic powered tools, and electrical and fiber optic assemblies principally used in the electrical construction and maintenance, plumbing, wiring, telecommunications, and data communications industries; and golf cars, professional turf-maintenance equipment, and off-road, multipurpose utility, and specialized turf-care vehicles that are marketed to golf courses, resort communities, municipalities, sporting venues, and commercial and industrial users. The Finance segment provides finance for aircraft, helicopters, and golf and turf-care equipment. The company sells its products through a network of sales representatives, distributors, and authorized independent sales representatives, as well as directly to end users, home improvement retailers, and original equipment manufacturers. Textron Inc. was founded in 1923 and is headquartered in Providence, the Rhode Island.
Advisors' Opinion:- [By Ben Levisohn]
Stallard sees KEYW Holding (KEYW) and Textron (TXT) potentially missing earnings, while Honeywell (HON),� Alliant Techsystems (ATK),�Lockheed Martin (LMT),�Raytheon (RTN) and�Wesco Aircraft (WAIR) could beat.
- [By Rich Smith]
Counting time
Granted, an Apache-Black Hawk solution would be only temporary -- in theory. The Army is currently developing an "Armed Aerial Scout," also known as an "Armed Reconnaissance Helicopter", or ARH, to replace the Kiowa. Most major defense contractors are bidding on the work -- Textron (NYSE: TXT ) , which builds the Kiowa, and also Lockheed Martin (NYSE: LMT ) , Boeing (NYSE: BA ) , United Technologies (NYSE: UTX ) , AgustaWestland, and even Airbus parent EADS.
Top 10 Information Technology Stocks To Buy Right Now: Canadian Mining Co Inc (CNG)
Canadian Mining Company Inc. (Canadian Mining) is engaged in the evaluation, acquisition, exploration, development and operation of mineral properties in British Columbia, Arizona, the United States and Sonora, Mexico. The Company�� projects include Bullard Pass Property, and Raquel 3 Concession. During the fiscal year ended June 30, 2012 (fiscal 2012), the Company had interests in two mineral properties located in British Columbia: Sun Group and Bromley Creek. In British Columbia, the Company�� principal property interest is its Bromley Creek zeolite project, which consists of a total of one mineral lease and six mineral claims. The Company has contiguous claim, number 305975, located in the Similkameen Mining District of British Columbia. The total claim area includes 843.468 hectares. During fiscal 2012, Canadian Mining completed phase one of a drilling program in Bullard Pass Gold Property. Advisors' Opinion:- [By Tyler Laundon]
It has a vision of building America's Natural Gas Highway. The project consists of a compressed natural gas (CNG) and liquefied natural gas (LNG) fuel-station network connecting 48 states.
Top 10 Information Technology Stocks To Buy Right Now: Integra LifeSciences Holdings Corp (IART)
Integra LifeSciences Holdings Corporation (Integra), incorporated on June 19, 1989, is an integrated medical technology company. Integra offers solutions in orthopedic extremity surgery, neurosurgery, spine surgery, and reconstructive and general surgery. The Company has developed numerous product lines for applications ranging from burn and deep tissue wounds to regeneration of dura mater in the brain and repair of nerve and tendon. It operates in five business segments: U.S. Neurosurgery, U.S. Extremities, U.S. Instruments, U.S. Spine and Other, and International. The International segment sells similar products to Europe, Middle East and Africa, and Central/South America, Asia-Pacific and Canada. On April 29, 2013, the Company launched the Integra Compact Cranial Closure System, which provides titanium implants for non-loadbearing (non-facial) operative cranial neurosurgical procedures. On April 30, 2013, it released its Hollywood VI intervertebral body fusion device (IBD) system. In January 2014, Integra LifeSciences Holdings Corp completed the acquisition of DuraSeal product lines from Covidien. In January 2014, Covidien PLC completed the sale of its Confluent Surgical product line to Integra LifeSciences Corporation.
U.S. Neurosurgery
The Company�� U.S. Neurosurgery sales organization sells a full line of products for neurosurgery and neuro critical care. It has products for each step of a cranial procedure and the care of the patient after surgery. Its key products include dural repair products, cerebral spinal fluid (CSF) management devices, tissue ablation equipment, intracranial monitoring equipment and cranial stabilization equipment. The Company sells equipment used in the neurosurgery operating room and neurosurgery intensive care unit (NICU).
U.S. Extremities
Extremity reconstruction includes the repair of soft tissue and the orthopedic reconstruction of bone in the foot, ankle and leg below the knee (Lower Extremity), and the hand, ! wrist, elbow and shoulder (Upper Extremity). Its key products include bone and joint fixation devices, implants and instruments for osteoarthritis, rheumatoid arthritis, wrist arthroplasty, carpel tunnel syndrome, and cubital tunnel syndrome. Other key products include its regenerative medicine devices for the treatment of acute and chronic wounds, peripheral nerve repair and protection and tendon repair, and bone graft substitutes.
U.S. Instruments
Integra�� U.S. Instruments business is a surgical instrument suppliers in the United States. Its portfolio includes over 60,000 instrument patterns and surgical products sold a range of users, including hospitals, surgery centers, and physician, dental and veterinary offices. In addition to selling hand-held instruments, it sells surgical headlight systems and table-mounted retractors. The Company�� brands include Jarit, Miltex, Padgett, Ruggles, Luxtec and Omni-Tract.
U.S. Spine and Other
Integra�� U.S. Spine and Other segment offer spinal fusion technologies that surgeons use along the full length of the spine, as well as a range of related orthobiologics. During the year ended December 31, 2012, its Spine business launched multiple new implants into the integrated interbody fusion device market and the deformity market. Its key spinal hardware products include integrated interbody fusion devices, minimally invasive solutions, and deformity correction. It markets and sells a complete line of orthobiologics, including demineralized bone products, collagen ceramic matrices and pure synthetic bone grafting solutions, to neurosurgeons, and spine, orthopedic, trauma, and foot and ankle surgeons. Integra sells its products through specialty distributors focused on its spine and orthopedic surgeon customers, as well as through some direct sales representatives. This segment also includes private-label sales of a set of its regenerative medicine technologies. Its customers are other large medical technology! companie! s that sell to end markets primarily in orthopedics and wound care.
The Company competes with Johnson & Johnson, Synthes, Inc., Stryker Corporation, Tornier, Inc., Wright Medical Group, Inc., Zimmer, Inc., Small Bone Innovations, Inc., Medtronic, Inc., Globus Medical Inc., NuVasive, Inc., Orthofix, Alphatec Spine, Inc., B. Braun Medical Inc., CareFusion and Symmetry Medical.
Advisors' Opinion:- [By Keith Speights]
Recall recoil
Medical instrument maker Integra LifeSciences (NASDAQ: IART ) shares dropped 11% this week. The stock's fall stemmed from a product recall announced on Wednesday.� - [By Ben Levisohn]
Shares of Align have surged 24% to $57 at 12:37 p.m. Sirona Dental Systems (SIRO) has risen 0.8% to $69.61, Dentsply International (XRAY) is up 0.1% at $45.44, Integra Lifesciences (IART) has� gained 0.4% to $44.23 and Danaher (DHR) has fallen 0.3% to $72.13.
No comments:
Post a Comment